Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021144274 - USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF JOINT PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONS

Publication Number WO/2021/144274
Publication Date 22.07.2021
International Application No. PCT/EP2021/050499
International Filing Date 12.01.2021
IPC
A61K 31/706 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7052having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
706containing six-membered rings with nitrogen as a ring hetero atom
A61P 19/02 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
A61P 29/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
Applicants
  • NUVAMID SA [CH]/[CH]
Inventors
  • BERMOND, Guillaume
  • GARCON, Laurent
Agents
  • AUGUST DEBOUZY
Priority Data
FR200027013.01.2020FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF JOINT PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONS
(FR) UTILISATION DE NMN POUR LA PREVENTION ET/OU LE TRAITEMENT D'UNE DOULEUR ARTICULAIRE INDUITE PAR L'ACTIVITE PHYSIQUE ET COMPOSITIONS CORRESPONDANTES
Abstract
(EN)
The invention relates to a nicotinamide mononucleotide, one of the pharmaceutically acceptable derivatives thereof or one of the pharmaceutically acceptable salts thereof, for use in the prevention and/or treatment of joint pain induced by physical activity, as well as to compositions comprising same.
(FR)
L'invention porte sur le nicotinamide mononucléotide, un de ses dérivés pharmaceutiquement acceptables ou un de ses sels pharmaceutiquement acceptables, pour son utilisation dans la prévention et/ou le traitement d'une douleur articulaire induite par l'activité physique ainsi que les compositions le comprenant.
Latest bibliographic data on file with the International Bureau